LIFECORE BIOMEDICAL INC (LFCR)

US5147661046 - Common Stock

7.24  +0.17 (+2.4%)

After market: 7.2393 0 (-0.01%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
185.8M
8.34%
103.269M
-44.42%
128.261M
24.20%
131.12M
2.23%
142.14M
8.40%
158.47M
11.49%
176.15M
11.16%
EBITDA
YoY % growth
14.38M
-43.09%
-6.435M
-144.75%
1.671M
125.97%
19.604M
1,073.19%
25.091M
27.99%
32.346M
28.91%
N/A
EBIT
YoY % growth
-3.5M
-164.81%
-19.72M
-463.43%
-7.188M
63.55%
-11.423M
-58.91%
-2.795M
75.53%
2.731M
197.69%
N/A
Operating Margin
-1.88%-19.10%-5.60%-8.71%-1.97%1.72%N/A
EPS
YoY % growth
-0.27
-145.45%
-1.67
-518.52%
N/A
125.04%
-1.00
-340.24%
-0.73
27.41%
-0.58
20.28%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.31
-335.71%
-0.16
-158.33%
-0.03
85.00%
-0.32
35.47%
-0.23
26.23%
-0.15
6.45%
-0.03
-20.00%
-0.34
-6.45%
-0.22
2.22%
-0.15
-3.45%
-0.07
-133.33%
Revenue
Q2Q % growth
30.342M
0.64%
35.432M
-0.76%
40.144M
5.96%
27.62M
11.80%
33.197M
9.41%
38.573M
8.86%
42.762M
6.52%
33.503M
21.30%
38.426M
15.75%
43.768M
13.47%
46.515M
8.78%
EBITDA
Q2Q % growth
2.641M
-13.35%
6.68M
3.04%
12.112M
3.12%
194.137K
103.52%
4.521M
71.19%
7.401M
10.79%
12.974M
7.12%
3.032M
1,461.79%
7.072M
56.43%
10.089M
36.32%
11.278M
-13.07%
EBIT
Q2Q % growth
-4.835M
-264.67%
-144.84K
-16.81%
5.373M
86.11%
-6.579M
12.30%
-2.386M
50.65%
341.017K
335.44%
5.828M
8.47%
-3.886M
40.93%
-191.76K
91.96%
2.451M
618.73%
5.489M
-5.82%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
-0.49
-84.77%
-0.47-0.02-3.31%
Q4 2024
Q2Q % growth
-0.17
80.90%
-0.12-0.05-38.89%
Q3 2024
Q2Q % growth

72.18%
-0.06%
Q2 2024
Q2Q % growth

70.25%
-0.07%
Q1 2024
Q2Q % growth

17.13%
-0.27%
Q4 2023
Q2Q % growth
-0.89
-8,800.00%
-0.38-0.51-132.68%
Q3 2023
Q2Q % growth
-0.22
-175.00%
-0.13-0.09-65.91%
Q2 2023
Q2Q % growth
-0.24
-580.00%
-0.04-0.20-488.24%
Q1 2023
Q2Q % growth
-0.32
-39.13%
-0.14-0.18-132.39%
Q4 2022
Q2Q % growth
-0.01
-114.29%
-0.010.0026.45%
Q3 2022
Q2Q % growth
-0.08
11.11%
-0.01-0.07-1,468.63%
Q2 2022
Q2Q % growth
0.05
150.00%
-0.040.09222.55%
Q1 2022
Q2Q % growth
-0.23
-109.09%
-0.12-0.11-94.39%
Q4 2021
Q2Q % growth
0.07
40.00%
-0.010.08957.84%
Q3 2021
Q2Q % growth
-0.09
-325.00%
0.02-0.11-467.65%
Q2 2021
Q2Q % growth
0.02
112.50%
0.010.0196.08%
Q1 2021
Q2Q % growth
-0.11
31.25%
-0.110.001.96%
Q4 2020
Q2Q % growth
0.05
600.00%
0.030.0278.25%
Q3 2020
Q2Q % growth
0.04 0.030.0156.86%
Q2 2020
Q2Q % growth
-0.16 -0.06-0.10-161.44%
Q1 2020
Q2Q % growth
-0.16
-1,700.00%
-0.160.00-0.55%
Q4 2019
Q2Q % growth
-0.01
-104.17%
-0.020.0150.98%
Q3 2019
Q2Q % growth
0.04
-55.56%
0.030.0130.72%
Q2 2019
Q2Q % growth
0.00
-100.00%
-0.020.02100.00%
Q1 2019
Q2Q % growth
0.01
-87.50%
0.000.01194.41%
Q4 2018
Q2Q % growth
0.24 0.220.029.44%
Q3 2018
Q2Q % growth
0.09 0.090.00-1.96%
Q2 2018
Q2Q % growth
0.02 0.010.0156.86%
Q1 2018
Q2Q % growth
0.08 0.060.0230.72%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
24.705M
0.75%
23.652M1.053M4.45%
Q4 2024
Q2Q % growth
37.886M
20.10%
35.715M2.171M6.08%
Q3 2024
Q2Q % growth
35.704M
29.36%
36.483M-779K-2.14%
Q2 2024
Q2Q % growth
30.15M
343.38%
30.359M-209K-0.69%
Q1 2024
Q2Q % growth
24.522M
-43.50%
24.907M-385K-1.55%
Q4 2023
Q2Q % growth
31.546M
-33.73%
29.604M1.942M6.56%
Q3 2023
Q2Q % growth
27.6M
-26.20%
28.558M-958K-3.35%
Q2 2023
Q2Q % growth
6.8M
-38.74%
47.539M-40.739M-85.70%
Q1 2023
Q2Q % growth
43.4M
4.33%
43.592M-192K-0.44%
Q4 2022
Q2Q % growth
47.6M
6.01%
46.46M1.14M2.45%
Q3 2022
Q2Q % growth
37.4M
-16.33%
49.382M-11.982M-24.26%
Q2 2022
Q2Q % growth
11.1M
120.67%
43.794M-32.694M-74.65%
Q1 2022
Q2Q % growth
41.6M
-69.32%
131.7M-90.1M-68.41%
Q4 2021
Q2Q % growth
44.9M
116.37%
127.07M-82.17M-64.67%
Q3 2021
Q2Q % growth
44.7M
-70.77%
142.55M-97.85M-68.64%
Q2 2021
Q2Q % growth
-53.7M
-137.66%
136.93M-190.63M-139.22%
Q1 2021
Q2Q % growth
135.6M
-2.24%
130.41M5.19M3.98%
Q4 2020
Q2Q % growth
-274.2M
-280.04%
159.21M-433.41M-272.23%
Q3 2020
Q2Q % growth
152.9M
-1.74%
151.78M1.12M0.74%
Q2 2020
Q2Q % growth
142.6M
14.45%
145.39M-2.79M-1.92%
Q1 2020
Q2Q % growth
138.7M
11.23%
133.76M4.94M3.69%
Q4 2019
Q2Q % growth
152.3M
32.32%
153.24M-940K-0.61%
Q3 2019
Q2Q % growth
155.6M
7.38%
159.6M-4M-2.51%
Q2 2019
Q2Q % growth
124.6M
1.71%
128.56M-3.96M-3.08%
Q1 2019
Q2Q % growth
124.7M
7.69%
126.42M-1.72M-1.36%
Q4 2018
Q2Q % growth
115.1M 141.39M-26.29M-18.59%
Q3 2018
Q2Q % growth
144.9M 149.01M-4.11M-2.76%
Q2 2018
Q2Q % growth
122.5M 138.52M-16.02M-11.57%
Q1 2018
Q2Q % growth
115.8M 125.46M-9.66M-7.70%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -103.33% 0% 0.51%
Revenue0% -15.85% 0% 0.4%